This invention relates to novel compounds of the invention pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11β-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of cortisol in a cell or the inhibition of the conversion of cortisone to cortisol in a cell.
本发明涉及本发明的新化合物及其药学上可接受的盐和药物组合物,对于治疗与哺乳动物中的11β-H
SD1的调节或抑制相关的疾病是有用的。本发明还涉及所述新化合物的药物组合物和其在细胞中降低或控制
皮质醇的产生或抑制
皮质酮转化为
皮质醇的方法。